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CTPA for the diagnosis of acute pulmonary
embolism during pregnancy
Abstract CT pulmonary angiography
(CTPA) has been suggested by the
Fleischner society as the first test
following a negative leg ultrasound in
pregnant patients with suspected
pulmonary embolism. This editorial
discusses the use of CTPA as a
diagnostic tool in pregnant women
and comments on the need for speci-
fically adapting CT protocols during
pregnancy in the light of new research
describing a substantial number of
non-diagnostic examinations in preg-
nant women if routine scanning
protocols are used for CTA of the
pulmonary arteries. Potential reasons
for these high numbers of insufficient
examinations are physiological
changes occurring during pregnancy
that lead to a hyperdynamic circula-
tion, which reduces average enhance-
ment of the pulmonary vasculature. In
addition, there are possible breathing-
related effects that include an in-
creased risk for Valsalva manoeuvre
with devastating effects for pulmonary
vascular enhancement. Techniques to
overcome these problems are dis-
cussed: bolus triggering with short
start delays, high flow rates or high
contrast medium concentration, pre-
ferential use of fast CT systems and
the use of low kVp CT techniques. CT
data acquisition during deep inspira-
tion should be avoided and shallow
respiration may be considered as an
alternative to suspended breathing in
this patient group. All these factors
can contribute to optimization of the
quality of pulmonary CTA in pregnant
patients. It is time now to adapt our
protocols and provide optimum care
for this sensitive patient group.
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Venous thrombo-embolic disease has a two- to fourfold
increased incidence during pregnancy and is a leading
cause of maternal mortality. Ultrasound of the leg veins
has been advocated as the first clinical test for suspected
non-life-threatening thrombo-embolism (Statement of
the Fleischer Society [1]) because further radiographic
imaging is only required if leg ultrasound is normal. The
question of which technique to use next for pregnant
patients with suspected thrombo-embolism has been hotly
debated.
Most investigators recommend CT pulmonary angiog-
raphy (CTPA) as the appropriate next test, but ventilation-
perfusion scintigraphy or half-dose perfusion scintigraphy
alone are still being discussed [2–4]. Relatively little focus
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has been put on MRA of the pulmonary arteries because of
the considerable level of expertise that needs to be
permanently available [5]. The argument that CTA is not
only able to directly demonstrate the embolus but also
detect or rule out alternative reasons for the patient’s
symptoms is a strong argument in favour of CTA. However,
small peripheral emboli that only manifest as a wedge-
shaped perfusion defect might be missed. Despite all the
limitations, it is generally considered safe to withhold
anticoagulation in case of either a normal CTA or perfusion
scan [6, 7].
Radiation dose is an important argument in the
discussion about the most appropriate technique, but fetal
dose with any of the present techniques is well below the
dose levels above which a significantly increased risk for
congenital abnormality has been proposed [8, 9]. Indepen-
dent of the fact that radiation dose is already relatively low,
any further reduction is welcome in the setting of
pregnancy because most of the risks of low-level radiation
are difficult to quantify and the risk of malignancy is
known to be increased in persons that have been exposed to
radiation in utero [10]. CTA has the intrinsic advantage that
the fetus is not directly exposed. In perfusion scintigraphy,
the need for intravenous injection of the radionucleotide
tracer will lead to perfusion-dependent direct fetal expo-
sure. Fetal exposure with CTA is, therefore, lower than
exposure with perfusion scintigraphy, even if a half-dose
scintigraphic technique is used [11, 12]. There is, however,
an underestimated radiation risk associated with pregnant
women: the proliferating breast tissue during pregnancy is
exposed directly. Because of the fact that the breast tissue is
located close to the skin, the breast dose is higher by a
factor of 2 than the effective dose given in the usual
discussions in the literature [13]. Whether this translates
into a measurable increase in breast cancer risk is not yet
known. Radiation dose with CTA, however, is strongly
dependent on the chosen examination parameters: by
optimizing scanning technique, for example by using low
kVp settings [14], radiation dose can be reduced and
vascular contrast can be increased.
The effect of iodinated or gadolinium-based contrast
agents on the fetus and the mother has been discussed [15].
Although there is no indication of fetal or maternal damage
in patients with normal renal function, it is agreed that the
volume of contrast material should be kept as low as
reasonably possible [15].
Despite the fact that there is growing consensus that
CTPA should be the next test after leg ultrasound in
pregnant patients with suspected pulmonary embolism,
there are no large-scale studies evaluating the efficacy of
CTPA during pregnancy yet. In clinical practice, however,
CTPA in pregnant women appears to be less robust than
expected because of variable image quality. This clinical
observation has been investigated by two retrospective
studies published in this issue of European Radiology [16,
17]. Both studies found—by subjective evaluation and
objective quantification—a significantly lower enhance-
ment of the pulmonary arteries in pregnant women than in
non-pregnant women of comparable age.
Although the two studies differ with respect to scan
speed, examination protocols and methods of image
evaluation, the reduction of contrast enhancement (mean
259HU in pregnant vs 371HU in non-pregnant women
[17]) and the increase in number of inadequate exams was
marked and statistically significant (7.5% vs 27.5% [16]).
One study even noted a higher number of segments that
could not be properly evaluated (13.3% vs 28.7%, p=
0.0001 [16]), a fact that has a potential influence on the
ability of CTA to rule out embolism. This reduced contrast
enhancement in pregnant women can have a number of
reasons: hyperdynamic circulation with increased cardiac
output, increased plasma volume, increased body weight
and more pronounced effects of a Valsalva manoeuvre.
Cardiac output increases during pregnancy initially due
to increased heart rate, later followed by an increase of
stroke volume as well [18]. Cardiac output of up to 50%
above non-pregnant levels [19] will lead to stronger
dilution of contrast media during the first pass and will
lead to proportionally lower contrast enhancement. Plasma
volume increases with pregnancy but also with body weight
and leads to dilution of contrast material during the re-
circulation phase. These physiological changes start to take
place alreadywithin the first trimester and increasewithin the
last trimester [20]. The effects of cardiac output and plasma
volume on enhancement were predicted theoretically and
verified in an animal model by Bae and co-workers in the
1990s [21]. Although these publications have focussed on
the systemic and not the pulmonary circulation, the following
assumptions can be derived from these studies:
. Arrival time of contrast material (10% of peak
enhancement) is inversely related to cardiac output
and flow rate of contrast injection
. Contrast enhancement peaks after a time interval that is
identical to the injection time
. Peak enhancement increases with iodine delivery rate
(iodine concentration and flow rate) and with total
iodine (iodine concentration and contrast volume)
. Peak enhancement is inversely proportional to cardiac
output and body weight
Most of these assumptions have found their way into the
way modern contrast injection protocols are designed [22,
23]. The effects of cardiac output, however, have not been
included in most protocols because it is difficult to
establish cardiac output non-invasively prior to a CT
examination. Test bolus techniques, which could serve that
purpose, have not been widely adopted in clinical routine
application [24]. As a consequence, contrast injection
protocols for pulmonary CTA have not taken into account
the physiological changes occurring during pregnancy,
with the result that many routine examinations (7.5% vs
27.5% [16]) are not fully diagnostic. The authors of the two
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studies published in this issue [16, 17] have to be
congratulated for drawing attention to the need for
adaptating contrast injection protocols in pregnancy.
How would such an adaptation look? Because of the
increased cardiac output, contrast material will arrive earlier
and peak enhancement will be lower than in non-pregnant
women. As a consequence, start delays have to be shortened
while iodine delivery rates have to be increased. A fixed start
delay of 20 s as used by ref. [17] is no longer appropriate:
bolus triggering, because of the shorter delay ideally located
in the pulmonary trunk, will allow for compensating for the
intra-individual variations and guarantee that no extra contrast
material needs to be injected to ensure good enhancement
with variable contrast arrival times. Iodine delivery rates can
be increased by choosing a contrast agent with higher iodine
concentration (350–400 mg/ml) or by increasing the flow
rate of contrast injection. With the advent of multidetector
CT, flow rates have been continuously increased and initial
fears of contrast extravasation at high flow rates have been
overcome. However, to compensate for an increase in cardiac
output by 50%, the flow rates need to be raised from 4ml/s to
6 ml/s. A combined approach, with increased flow rate and
contrast concentration, therefore appears warranted. Such an
approach should be able to compensate for the 35% decrease
in enhancement seen in the study by ref. [17]. An increase in
flow rate, however, also requires an increase in contrast
volume to ensure that contrast enhancement does not decrease
prematurely. In order to minimize the amount of contrast
agent injected, the injection time should be adapted to scan
duration and start delay after contrast arrival in the pulmonary
artery. Given the hyperdynamic state in pregnant patients, a
short start delay of 4–5 s after reaching the trigger level
appears appropriate. Injection time then will depend on the
speed of the scanner: a four-slice scanner with 20-s scan
duration will require substantially more contrast volume than
a 64-slice scanner with 5-s scan duration. At a flow rate of
6 ml/s that translates into contrast volumes of 150 ml (25s at
6ml/s) for four-slice scanners and 60 ml (10s at 6 ml/s) for
64-slice scanners. The fastest available scanner should,
therefore, be chosen for pregnant patients.
In clinical practice, adaptation of contrast injection to
scanner type or even individual patients is frequently not
performed. Ref. [16] used the same contrast injection
protocol for their 16-slice and 64-slice scanner despite the
fact that the 64-slice scanner was trice as fast. Ref. [17]
used fixed delays and a long contrast injection on their
four-slice scanner. Flow rates varied between 3 ml/s and
4 ml/s. Most patients were studied with standard 300 mg
iodine/ml contrast concentration. In one study, contrast
protocols were quite variable [17]. These parameters reflect
current clinical practice that frequently yields sufficient
results for elderly and non-pregnant patients. The sub-
stantial increase in cardiac output than can be expected in
young pregnant women will lead to the substantial
detrimental effects on image quality described by the two
groups of authors. These effects ranged from significantly
reduced average enhancement (259HU vs 371HU [17],
230HU vs 275HU [16]) to diagnostically insufficient
enhancement in up to 28.7% vs 13.3% of segmental
arteries [16] and to a significantly higher number of scans
(27.5% vs 7.5%) that were considered non-diagnostic [16].
Given optimized contrast injection protocols to start with,
these effects would probably have been less pronounced.
There are other factors, however, that cannot be controlled
by contrast injection protocols alone. Physiological changes
in respiration during pregnancy may also contribute to the
differences in pulmonary enhancement. Deep inspiration in
pregnant women may increase the influx of non-contrasted
blood via the inferior vena cava into the right atrium. The risk
for and the strength of a Valsalva manoeuvre may increase in
pregnant women due to psychological stress factors and
higher levels of anxiety. The Valsalva manoeuvre will
increase intra-thoracic pressure and substantially lower
contrast media influx. The effects are especially devastating
for examinations with fast scanners and short and ultra-short
examination times. Careful instruction of the patient is
necessary.Modest inspiration or even shallow breathingmay
be preferable over breath-holding after deep inspiration.
Optimization of contrast injection and breathing tech-
nique may not be the only way to improve contrast
enhancement in this patient group. Low kVp techniques
have been shown to substantially increase contrast en-
hancement as well. In fact, this effect is so pronounced that
reducing the tube voltage can more than compensate for the
reduction of enhancement found in the present studies.
Reducing the voltage from 140 kVp to 100 kVp was shown
to increase average main pulmonary artery enhancement by
40% and increase enhancement for small arteries even
more [14]. Most studies have used this increased enhance-
ment to reduce radiation dose without affecting signal to
noise, but in pregnant women the use of 80–100 kVp—
depending on patient size—may help counteract the
reduction of contrast enhancement seen in pregnancy.
The two studies published in this issue have, for the first
time, highlighted the fact that routine contrast injection
protocols for CTA of the pulmonary arteries will lead to a
substantial number of non-diagnostic examinations in
pregnant women. This fact would re-open the discussion
about the best technique for diagnosing pulmonary embo-
lism in pregnant women were there not the option of
adapting scanning protocols to overcome this limitation:
bolus triggering with short start delays, high flow rates and
contrast concentration, preferential use of fast scanners and
the use of low kVp scanning techniques. All these factors
can further optimize the quality of pulmonary CTA in
pregnant patients. It is now time to adapt our protocols and
provide optimum care for this sensitive patient group.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
2707
References
1. Remy-Jardin M, Pistolesi M, Goodman
LR et al (2007) Management of
suspected acute pulmonary embolism
in the era of CT angiography: a
statement from the Fleischner society.
Radiology 245:315–329
2. Matthews S (2006) Imaging pulmonary
embolism in pregnancy: what is the
most appropriate imaging protocol? Br
J Radiol 79:441–444
3. Schuster ME, Fishman JE, Copeland JF
et al (2003) Pulmonary embolism in
pregnant patients: a survey of practices
and politics for CT pulmonary angiog-
raphy. AJR Am J Roentgenol
181:1495–1498
4. Boisille PM, Reddy SS, Villas PA et al
(1998) Pulmonary embolus in pregnant
patients: survey of ventilation-perfusion
imaging policies and practices. Radiol-
ogy 207:201–206
5. van Beek EJ, Wild JM, Fink C et al
(2003) MRI for the diagnosis of pul-
monary embolism. J Magn Reson Imag
18:627–640
6. Quiroz R, Kucher N, Zou KH et al
(2005) Clinical validity of a negative
computed scan of patients with sus-
pected pulmonary embolism: a sys-
tematic review. JAMA 293:2012–2017
7. Chan WS, Ray JG, Murray S et al
(2002) Suspected pulmonary embolism
in pregnancy: clinical presentation, re-
sults of lung scanning, and subsequent
maternal and pediatric outcomes. Arch
Int Med 162:1170–1175
8. International Commission on Radio-
logical Protection (2000) Publication
84: Pregnancy and medical radiation.
Ann ICRP 30:1–43
9. Mallik S, Petkova D (2006) Investi-
gating suspected pulmonary embolism
during pregnancy. Respir Med
100:1682–1687
10. Preston DL, Cullings H, Suyama A et
al (2008) Solid cancer incidence in
atomic bomb survivars exposed in
utero or as young children. J Nat
Cancer Inst 100:428–436
11. Nijkeuter M, Geleijns K, De Roos A
(2004) Diagnosing pulmonary embo-
lism in pregnancy rationalizing fetal
radiation exposure in radiological pro-
cedures. J Thromb Haemost 2:1857–
1858
12. Cook JV, Kyriou J (2005) Radiation
from CT and perfusion scanning in
pregnancy. BMJ 331:350; erratum BMJ
2005; 331:613
13. Hurwitz LM, Reimann RE, Yoshizumi
TT et al (2007) Radiation dose from
contemporary cardiothoracic multide-
tector CT protocols with an anthropo-
morphic female phantom: Implications
for cancer induction. Radiology
245:742–750
14. Schueller-Weidekamm C, Schaefer-
Prokop C, Weber M, Herold CJ,
Prokop M (2006) CT angiography of
pulmonary arteries to detect pulmonary
embolism: improvement of vascular
enhancement with low kilovoltage set-
tings. Radiology 241:899–907
15. Webb JAW, Thomsen HS, Morcos SK;
Members of Contrast Media Safety
Committee of European Society of
Urogenital Radiology (ESUR)
(2005) The use of iodinated and
gadolinium contrast media during
pregnancy and lactation. Eur Radiol
15:1234-1240
16. U-King-Im JM, Freeman SJ, Cheow
HK (2008) Quality of CT pulmonary
angiography for suspected pulmonary
embolus in pregnancy. Eur Radiol
doi:10.1007/s00330-008-1100-0
17. Andreou AK, Curtin JJ, Wilde S, Clark
A (2008) Does pregnancy affect vas-
cular enhancement in patients under-
going CT pulmonary angiography? Eur
Radiol doi:10.1007/s00330-008-1114-7
18. Robson SC, Hunter S, Boys RJ,
Dunlop W (1989) Serial study of
factors influencing changes in cardiac
output during human pregnancy. Am J
Physiol 256:1060
19. Mabie WC, Disessa TG, Crocker LG et
al (1994) A longitudinal study of
cardiac output in normal human preg-
nancy. Am J Obstet Gynecol 170:849–
856
20. Duvekot JJ, Peeters LL (1994) Mater-
nal cardiovascular hemodynamic adap-
tation to pregnancy. Obstet Gynecol
Surv 49(Suppl 12):S1–S14
21. Bae KT, Heiken JP, Brink JA (1998)
Aortic and hepatic contrast medium
enhancement at CT: part II: effect of
reduced cardiac output in a porcine
model. Radiology 207:637–662
22. Mahnken AH, Rauscher A, Klotz E et
al (2007) Quantitative prediction of
contrast enhancement from test bolus
data in cardiac MSCT. Eur Radiol
17:1310–1319
23. Kanematsu M, Goshima S, Kondo H,
Bae KT (2008) How should we opti-
mize bolus tracking with multidetector
CT of the abdomen? Radiology
246:643; author reply 643–644
24. Bae KT (2005) Test-bolus versus bolus
tracking techniques for CT angio-
graphic timing. Radiology 236:369–70
2708
